🟢 Krystal Biotech is trading 5.89% up in pre-market

Krystal Biotech is trading 5.89% up at $368.60, with the catalyst uncertain.

• No fresh earnings release, FDA decision, acquisition, or other definitive catalyst was identified for September 10, 2026.
• The company is scheduled to present at the Cantor Global Healthcare Conference at 3:55 p.m. ET, but available sources do not directly link it to the pre-market move.
• Broader futures are mixed, and the move remains catalyst-uncertain pending the presentation or additional disclosures.